Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001415889-20-000880

CHIEF EXECUTIVE OFFICER bought 3,000 shares at $0.12 ($360)

From the SEC's structured data for this filing

Trades in this filing

Trieu Vuong · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-03-26 Purchase : show line 1 in the form +3,000 $0.12 $360 15,761,808 D
Open-market purchases · 3,000 sh · avg $0.12 · $360
Loading xslF345X03/form4-03272020_020342.xml…